Insider Transactions in Q2 2025 at Ginkgo Bioworks Holdings, Inc. (DNA)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2025
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,822
+50.0%
|
-
|
|
Jun 11
2025
|
Harry Sloan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,822
+3.83%
|
-
|
|
Jun 11
2025
|
Kathy Hopinkah Hannan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,822
+41.91%
|
-
|
|
Jun 11
2025
|
Christian O Henry Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,822
+19.63%
|
-
|
|
Jun 11
2025
|
Sri Kosuri Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,067
+50.0%
|
-
|
|
Jun 11
2025
|
Shyam Sankar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,822
+13.01%
|
-
|
|
Jun 11
2025
|
Ross Fubini Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,822
+50.0%
|
-
|
|
May 21
2025
|
Mark E. Dmytruk Officer |
SELL
Open market or private sale
|
Direct |
706
-1.5%
|
$4,942
$7.58 P/Share
|
|
May 21
2025
|
Steven P. Coen Officer |
SELL
Open market or private sale
|
Direct |
346
-3.62%
|
$2,422
$7.58 P/Share
|
|
May 20
2025
|
Mark E. Dmytruk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,479
+1.05%
|
-
|
|
May 20
2025
|
Steven P. Coen Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
743
+3.74%
|
-
|
|
Apr 21
2025
|
Mark E. Dmytruk Officer |
SELL
Open market or private sale
|
Direct |
1,244
-2.66%
|
$8,708
$7.28 P/Share
|
|
Apr 21
2025
|
Steven P. Coen Officer |
SELL
Open market or private sale
|
Direct |
997
-10.16%
|
$6,979
$7.28 P/Share
|
|
Apr 17
2025
|
Mark E. Dmytruk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,548
+1.1%
|
-
|
|
Apr 17
2025
|
Steven P. Coen Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,804
+5.97%
|
-
|